Name: Gastroretentive Drug Delivery System Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: PH4003
Price: 4350 USD
Availability: InStock

Gastroretentive Drug Delivery System Market Size, Report 2023-2030

Gastroretentive Drug Delivery System Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Market Snippet by Type</li>
		<li>Market Snippet by Dosage Form</li>
		<li>Market Snippet by Distribution Channel</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increase in number of various disorders related to small intestine and stomach will drive the market growth</li>
				<li>The curative efficiency and the increase in bioavailability of drugs</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Floating drug delivery system require high fluid availability in the stomach to float and work effectively</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	<h3>COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>By Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment</li>
			<li>Market Attractiveness Index, By Type&nbsp; Segment</li>
		</ol>
		</li>
		<li>Floating drug delivery system *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Bioadhesive drug delivery system</li>
		<li>Other</li>
	</ol>
	</li>
	<li>
	<h3>By Dosage Form</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form</li>
			<li>Market Attractiveness Index, By Dosage Form</li>
		</ol>
		</li>
		<li>Tablets*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Capsule</li>
		<li>Microspheres</li>
		<li>Liquid</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3>By Distribution Channel</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Attractiveness Index, By Distribution Channel</li>
		</ol>
		</li>
		<li>Online pharmacies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>Retail Pharmacies</li>
		<li>Hospital pharmacies</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Dosage Form</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>

	<ol>
		<li>Galenix*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Pharmacia</li>
		<li>&nbsp;Depomed</li>
		<li>&nbsp;Ranbaxy</li>
		<li>&nbsp;Sun Pharma</li>
		<li>Pfizer</li>
		<li>&nbsp;Lupin</li>
		<li>&nbsp;Glaxo Smith Klike</li>
		<li>&nbsp;F.Hoffmann La Roch</li>
		<li>&nbsp;ALCON, INC.(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	<h3>DataM Intelligence</h3>

	<ol>
		<li>Appendix</li>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 01 Gastroretentive Drug Delivery System Market Value, By Type, 2021, 2025 &amp; 2029($ Million)

Table 02 Gastroretentive Drug Delivery System Market Value, By Dosage Form, 2021, 2025 &amp; 2029($ Million)

Table 03 Gastroretentive Drug Delivery System Market Value, By Distribution Channel, 2021, 2025 &amp; 2029($ Million)

Table 04 Gastroretentive Drug Delivery System Market Value, By Region, 2021, 2025 &amp; 2029($ Million)

Table 05 Gastroretentive Drug Delivery System Market Value, By Type, 2021, 2025 &amp; 2029($ Million)

Table 06 Gastroretentive Drug Delivery System Market Value, By Type, 2018-2029($ Million)

Table 07 Gastroretentive Drug Delivery System Market Value, By Dosage Form, 2021, 2025 &amp; 2029($ Million)

Table 08 Gastroretentive Drug Delivery System Market Value, By Dosage Form, 2018-2029($ Million)

Table 09 Gastroretentive Drug Delivery System Market Value, By Distribution Channel, 2021, 2025 &amp; 2029($ Million)

Table 10 Gastroretentive Drug Delivery System Market Value, By Distribution Channel, 2018-2029($ Million)

Table 11&nbsp; Gastroretentive Drug Delivery System Market Value, By Region, 2021, 2025 &amp; 2029($ Million)

Table 12 Gastroretentive Drug Delivery System Market Value, By Region, 2018-2029($ Million)

Table 13 North America Gastroretentive Drug Delivery System Market Value, By Type, 2018-2029($ Million)

Table 14 North America Gastroretentive Drug Delivery System Market Value, By Dosage Form, 2018-2029($ Million)

Table 15 North America Gastroretentive Drug Delivery System Market Value, By Distribution Channel, 2018-2029($ Million)

Table 16 North America Gastroretentive Drug Delivery System Market Value, By Country, 2018-2029($ Million)

Table 17&nbsp; South America Gastroretentive Drug Delivery System Market Value, By Type, 2018-2029($ Million)

Table 18 South America Gastroretentive Drug Delivery System Market Value, By Dosage Form, 2018-2029($ Million)

Table 19 South America Gastroretentive Drug Delivery System Market Value, By Distribution Channel, 2018-2029($ Million)

Table 20 South America Gastroretentive Drug Delivery System Market Value, By Country, 2018-2029($ Million)

Table 21 Europe Gastroretentive Drug Delivery System Market Value, By Type, 2018-2029($ Million)

Table 22 Europe Gastroretentive Drug Delivery System Market Value, By Dosage Form, 2018-2029($ Million)

Table 23 Europe Gastroretentive Drug Delivery System Market Value, By Distribution Channel, 2018-2029($ Million)

Table 24 Europe Gastroretentive Drug Delivery System Market Value, By Country, 2018-2029($ Million)

Table 25 Asia-Pacific Gastroretentive Drug Delivery System Market Value, By Type, 2018-2029($ Million)

Table 26 Asia-Pacific Gastroretentive Drug Delivery System Market Value, By Dosage Form, 2018-2029($ Million)

Table 27 Asia-Pacific Gastroretentive Drug Delivery System Market Value, By Distribution Channel,2018-2029($ Million)

Table 28 Asia-Pacific Gastroretentive Drug Delivery System Market Value, By Country, 2018-2029($ Million)

Table 29 Middle East &amp; Africa Gastroretentive Drug Delivery System Market Value, By Type, 2018-2029($ Million)

Table 30 Middle East &amp; Africa Gastroretentive Drug Delivery System Market Value, By Dosage Form, 2018-2029($ Million)

Table 31 Middle East &amp; Africa Gastroretentive Drug Delivery System Market Value, By Distribution Channel, 2018-2029($ Million)

Table 32 Galenix: Overview

Table 33 Galenix: Product Portfolio

Table 34 Galenix: Key Developments

Table 35 Pharmacia: Overview

Table 36 Pharmacia: Product Portfolio

Table 37 Pharmacia: Key Developments

Table 38 Sun Pharma: Overview

Table 39 Sun Pharma: Product Portfolio

Table 40 Sun Pharma: Key Developments

Table 41 Pfizer: Overview

Table 42 Pfizer: Product Portfolio

Table 43 Pfizer: Key Developments

Table 44 Lupin: Overview

Table 45 Lupin: Product Portfolio

Table 46 Lupin: Key Developments

Table 47 Glaxo Smith Klike: Overview

Table 48 Glaxo Smith Klike: Product Portfolio

Table 49 Glaxo Smith Klike: Key Developments

Table 50 Depomed: Overview

Table 51 Depomed: Product Portfolio

Table 52 Depomed: Key Developments

Table 53 F.Hoffmann La Roche: Overview

Table 54 F.Hoffmann La Roche: Product Portfolio

Table 55 F.Hoffmann La Roche: Key Developments

Table 56 Ranbaxy: Overview

Table 57 Ranbaxy: Product Portfolio

Table 58 Ranbaxy: Key Developments

Table 59 ALCON, INC.: Overview

Table 60 ALCON, INC.: Product Portfolio

Table 61 ALCON, INC.: Key Developments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

List of Figures

Figure 01 Gastroretentive Drug Delivery System Market Share, By Type, 2021 &amp; 2029 (%)

Figure 02 Gastroretentive Drug Delivery System Market Share, By Dosage Form, 2021 &amp; 2029 (%)

Figure 03 Gastroretentive Drug Delivery System Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 04 Gastroretentive Drug Delivery System Market Share, By Region, 2021 &amp; 2029 (%)

Figure 05 Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 06 Gastroretentive Drug Delivery System Market Y-o-Y Growth, By Type, 2021-2029 (%)

Figure 07 Bioadhesive drug delivery system: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 08&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Floating drug delivery system: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 09 Other: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 10 Gastroretentive Drug Delivery System Market Y-o-Y Growth, By Dosage Form, 2021-2029 (%)

Figure 11 Tablets: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 12 Microspheres: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 13 Capsule: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 14 Liquid: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 15 Others: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 16 Gastroretentive Drug Delivery System Market Y-o-Y Growth, By Distribution Channel, 2021-2029 (%)

Figure 17 Online pharmacies: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 18 RETAIL PHARMACIES: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 19 Hospital pharmacies: Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 20 Gastroretentive Drug Delivery System Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 21 North America Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 22 North America Gastroretentive Drug Delivery System Market Share, By Type, 2021 &amp; 2029 (%)

Figure 23 North America Gastroretentive Drug Delivery System Market Share, By Dosage Form, 2021 &amp; 2029 (%)

Figure 24 North America Gastroretentive Drug Delivery System Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 25 North America Gastroretentive Drug Delivery System Market Share, By Country, 2021 &amp; 2029 (%)

Figure 26 South America Gastroretentive Drug Delivery System Market Value, 2018-2029 ($ Million)

Figure 27 South America Gastroretentive Drug Delivery System Market Share, By Type, 2021 &amp; 2029 (%)

Figure 28 South America Gastroretentive Drug Delivery System Market Share, By Dosage Form, 2021 &amp; 2029 (%)

Figure 29 South America Gastroretentive Drug Delivery System Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 30 South America Gastroretentive Drug Delivery System Market Share, By Country, 2021 &amp; 2029 (%)

Figure 31 Europe Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 32 Europe Gastroretentive Drug Delivery System Market Share, By Type, 2021 &amp; 2029 (%)

Figure 33 Europe Gastroretentive Drug Delivery System Market Share, By Dosage Form, 2021 &amp; 2029 (%)

Figure 34 Europe Gastroretentive Drug Delivery System Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 35 Europe Gastroretentive Drug Delivery System Market Share, By Country, 2021 &amp; 2029 (%)

Figure 36 Asia-Pacific Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 37 Asia-Pacific Gastroretentive Drug Delivery System Market Share, By Type, 2021 &amp; 2029 (%)

Figure 38 Asia-Pacific Gastroretentive Drug Delivery System Market Share, By Dosage Form, 2021 &amp; 2029 (%)

Figure 39 Asia-Pacific Gastroretentive Drug Delivery System Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 40 Asia-Pacific Gastroretentive Drug Delivery System Market Share, By Country, 2021 &amp; 2029 (%)

Figure 41 Middle East &amp; Africa Gastroretentive Drug Delivery System Market Value, 2018-2029($ Million)

Figure 42 Middle East &amp; Africa Gastroretentive Drug Delivery System Market Share, By Type, 2021 &amp; 2029 (%)

Figure 43 Middle East &amp; Africa Gastroretentive Drug Delivery System Market Share, By Dosage Form, 2021 &amp; 2029 (%)

Figure 44 Middle East &amp; Africa Gastroretentive Drug Delivery System Market Share, By Distribution Channel, 2021 &amp; 2029 (%)

Figure 45 Galenix: Financials

Figure 46 Pharmacia: Financials

Figure 47 Sun Pharma: Financials

Figure 48 Pfizer: Financials

Figure 49 Lupin: Financials

Figure 50 Glaxo Smith Klike: Financials

Figure 51 Depomed: Financials

Figure 52 F.Hoffmann La Roche: Financials

Figure 53 Ranbaxy: Financials

Figure 54 ALCON, INC.: Financials